- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03959995
Effects of Physical Exercise on Postmenopausal Risk Factors in Women With Osteopenia (ACTLIFE)
Effects of an Optimized 13-month Physical Exercise on (Early)-Postmenopausal Risk Factors in Women With Osteopenia and Osteoporosis (Actlife)
Menopause usually have a serious impact on a woman's life, associated with negative consequences for health and quality of life. Early preventive assessments are very difficult to implement due to the complex hormone-deficiency-induced effects on a large variety of organs and systems with estrogen receptors. In fact, only a few types of interventions have the potential to comprehensively improve the various risk factors and complaints of the menopausal transition. In detail, however, not every form of exercise training or every training protocol is effective for exerting positive effects on selected risk factors. In particular, the training concept for addressing musculoskeletal or cardio-metabolic risk factors differ fundamentally.
In several studies, we confirmed the effect of different complex training programs on risk factors of different postmenopausal female cohorts with special consideration of osteoporotic aspects. The training programs applied in this context were characterized by the consistent implementation of recognized training principles and an in general exercise intensity-oriented approach. Recent studies confirmed the effectiveness of this proceeding for women with relevant postmenopausal risk factors including low bone strength. However, the crucial issue of the most effective, feasible and easily customizable training protocol for addressing postmenopausal risk factors remains to be answered, taking into account that the majority of exercise programs were realized in an ambulatory group setting.
The aim of the study will be to evaluate the effects of an optimized physical training on risk factors and complaints of (early) postmenopausal women with special consideration of the osseous fracture risk.
Note (05.06.2020): Of importance, the intervention has to be cancelled due to COVID-19 lockdown in March 2020 after 13 months of intervention.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Bavaria
-
Erlangen, Bavaria, Germany, 91052
- Institute of Medical Physics, Friedrich Alexander University Erlangen-Nürnberg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- (early)postmenopausal women, ( normal menopause, 1-5 years post)
- Osteopenia and osteoporosis at the lumbar spine or femoral neck Bone Mineral Density (BMD) <-1.0 standard deviation (SD) T-Score, WHO)
Exclusion Criteria:
- BMD <-4.0 SD T-Score (BMD threshold for pharmaceutical therapy according to Dachverband Osteologie (DVO) guideline (mandatory for Germany, Austria, Suisse) for woman 50-60 years).
- Prevalent clinical, low-trauma fractures
- Diseases and drugs with relevant effects on bone and muscle metabolism (e.g. glucocorticoids >7.5 mg/d or bisphosphonate therapy); individual case assessment
- Diseases and drugs with relevant effects on cardiometabolic risk factors (e.g. severe hypertension with corresponding medical therapy); individual case assessment
- Severe cardiovascular events (e.g. stroke, coronary infarction) in the past.
- Other conditions, diseases that exclude exercise training in a group (≤10 persons).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: exercise
Exercise group
|
Ambulatory, consistently supervised group exercise training (3 training sessions of 40-45 min/week each).
10-12-week blocks of non-linearly periodized high intensity resistance and high impact aerobic dance exercises (HIT-setting) intermitted by 4-6-week periods of endurance-type exercise with high volume and lower intensity.
Indi-vidualized training schedules for the RT-section.
|
SHAM_COMPARATOR: control
active control group
|
control group: 3x 10 week blocks, 1 training session/week à 45 min; stretching, light functional gymnastics, yoga with less strengthening techniques over 13 months.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
BMD Lumbar Spine
Time Frame: from baseline to 13 month follow-up
|
Bone Mineral Density (BMD) at the lumbar spine region of interest as determined by Dual Energy x-Ray Absorptiometry (DXA)
|
from baseline to 13 month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
BMD total Hip
Time Frame: from baseline to 13 month follow-up
|
Bone Mineral Density at the total hip region of interest as determined by DXA
|
from baseline to 13 month follow-up
|
Para-vertebral muscle density
Time Frame: from baseline to 13 month follow-up
|
Muscle density at the para-vertebral region as determined by Magnetic Resonance Imaging (MRI)
|
from baseline to 13 month follow-up
|
Mid-thigh muscle density
Time Frame: from baseline to 13 month follow-up
|
Muscle density at the mid-thigh region as determined by MRI
|
from baseline to 13 month follow-up
|
Metabolic Syndrome
Time Frame: from baseline to 13 month follow-up
|
Metabolic Syndrome Z-Score according to the Internationale Diabetes Federation (IDF)
|
from baseline to 13 month follow-up
|
Visceral body fat
Time Frame: from baseline to 13 month follow-up
|
Visceral body fat as determined by Magnetic Resonance Imaging (MRI)
|
from baseline to 13 month follow-up
|
Total body fat
Time Frame: from baseline to 13 month follow-up
|
Total body fat as determined by whole body DXA
|
from baseline to 13 month follow-up
|
Total Lean Body Mass
Time Frame: from baseline to 13 month follow-up
|
Total Lean Body Mass as determined by whole body DXA
|
from baseline to 13 month follow-up
|
Menopausal complaints
Time Frame: from baseline to 13 month follow-up
|
Menopausal complaints as determined by the Menopause Rating Scale (German version.
Questionnaire with 11 items; scale from 0 (no complaints/problems) to 4 (very severe complaints/problem)
|
from baseline to 13 month follow-up
|
Maximum leg strength
Time Frame: from baseline to 13 month follow-up
|
Maximum isokinetic leg extensor strength as determined by an isokinetic leg press
|
from baseline to 13 month follow-up
|
Total fat rate
Time Frame: from baseline to 13 month follow-up
|
Total fat rate as determined by Bio Impedance technique (BIA)
|
from baseline to 13 month follow-up
|
Fat free mass
Time Frame: from baseline to 13 month follow-up
|
Fat free mass as determined by BIA
|
from baseline to 13 month follow-up
|
Collaborators and Investigators
Investigators
- Principal Investigator: Michael Hettchen, MSc, Institute of Medical Physics, University of Erlangen-Nurnberg, Germany
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ER_ACTLIFE
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteopenia, Osteoporosis
-
University of Sao Paulo General HospitalCompletedOsteoporosis, Postmenopausal | Osteoporosis, OsteopeniaBrazil
-
Appalachian State UniversityNorth Carolina Agriculture & Technical State UniversityCompletedPostmenopausal Osteoporosis | Osteoporosis, OsteopeniaUnited States
-
Chinese PLA General HospitalBeijing Jishuitan Hospital; Beijing Aerospace General HospitalUnknownOsteoporosis | Osteopenia, OsteoporosisChina
-
NestléInstitut National de la Recherche Agronomique; Centre de Recherche en Nutrition...CompletedOsteoporosis, OsteopeniaFrance
-
MeddocThe Research Council of Norway; TineRecruitingOsteopenia or OsteoporosisNorway
-
Aarhus University HospitalCompleted
-
Umm Al-Qura UniversityCompletedOsteopenia or OsteoporosisSaudi Arabia
-
Riphah International UniversityCompletedPostmenopausal Osteoporosis | Postmenopausal OsteopeniaPakistan
-
University of ValenciaCompletedPhysical Activity | Osteoporosis, Postmenopausal | Osteoporosis, Osteopenia
-
Odense University HospitalNovo Nordisk A/S; Odense Patient Data Explorative NetworkRecruiting
Clinical Trials on High Intensity Resistance (HIT-RT) and Endurance exercise (HIIT)
-
Universidade Federal do Rio de JaneiroCompleted
-
Universidad Santo TomasUniversidad Pública de Navarra; Universidad del Rosario; Healthcare Center Tomas... and other collaboratorsCompletedInsulin Sensitivity | Obesity, Pediatric | Metabolism DisorderColombia
-
University of TorontoUniversity Health Network, TorontoTerminated
-
Diakonhjemmet HospitalThe Dam Foundation; The Norwegian Rheumatism Association; Norwegian Health AssociationCompletedRheumatoid Arthritis | Psoriatic Arthritis | SpondyloarthritisNorway
-
University of Castilla-La ManchaMinisterio de Economía y Competitividad, Spain; Biomedical Research Networking...CompletedFrail Elderly Syndrome | Sarcopenia | AgingSpain
-
University of Erlangen-Nürnberg Medical SchoolUnknownInflammation | Cancer | Cancer CachexiaGermany
-
Norwegian University of Science and TechnologyLHL-Klinikkene, Røros; LHL-Klinikkene, FeiringWithdrawnVentricular Dysfunction, Left | Heart Failure, DiastolicNorway
-
Northwestern UniversityRush University Medical Center; Shirley Ryan AbilityLabCompletedParkinson Disease | Mild Cognitive ImpairmentUnited States
-
Universität Duisburg-EssenRecruiting
-
Universidade Federal do vale do São FranciscoCompletedPost-Exercise Hypotension